Hong Chul Kim Board of Directors With over 30 years of expertise and leadership in finance and capital markets, Mr. Hong Chul Kim was appointed Chief Executive Officer of HLB ...
In Hae (Sydney) Jin Board of Directors In Hae (Sydney) Jin is currently engaged in alliance management at Elevar Therapeutics and corporate development at Verismo Therapeutics, two U.S.-based affiliates of ...
Ki Hong Ahn Board of Directors, CEO of HLB Therapeutics Ki Hong Ahn is the CEO of HLB Therapeutics, a South Korean KOSDAQ-listed pharmaceutical company specializing in new drug development. ...
Dong-Gun Kim Chief Executive Officer Dong-Gun (DG) Kim became CEO of Immunomic Therapeutics in 2023 after serving on the Company’s Board and as CEO of HLB from 2020. Before joining ...
Yoon Ki Baek Board of Directors Yoon-Ki Baek has been the Chief Executive Officer of HLB Co., Ltd. since July 2023. Mr. Baek brings over 37 years of experience in ...
Yang Gon Jin Chairman of the Board of Directors, Chairman of HLB Board Yang Gon Jin is the Chairman of the HLB Board and has been leading the rapid growth ...